Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration

Experimental Neurology

Volumn 155, Issue 1, 1999, Pages 59-64

  Mandel, R J ^a   Gage, F H ^b   Clevenger, D G ^a   Spratt, S K ^a   Snyder, R O ^a   Leff, S E ^a  

^a CELL GENESYS INC   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Basal forebrain; Gene therapy; Growth factors

Indexed keywords

ACETYLCHOLINE; GROWTH FACTOR; NERVE GROWTH FACTOR; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; FOREBRAIN; GENE TARGETING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033044592     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6961     Document Type: Article

References (39)

1. Blömer U., Kafri T., Randolph-Moore L., Verma I. M., Gage F. H. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc. Natl. Acad. Sci. USA. 95:1998;2603-2608.
2. Chamberlin N. L., Du B., De Lacalle S., Saper C. B. Recombinant adeno-associated virus vector: Use for transgene expression and anterograde tract tracing in the CNS. Brain Res. 793:1998;169-175.
3. Chen K. S., Gage F. H. Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration. J. Neurosci. 15:1995;2819-2825.
4. Day-Lollini P. A., Stewart G. R., Taylor M. J., Johnson R. M., Chellman G. J. Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor. Exp. Neurol. 145:1997;24-37.
5. Dekker A. J., Langdon D. J., Gage F. H., Thal L. J. NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis. NeuroRep. 2:1991;577-580.
6. Fischer W., Bjorklund A. Loss of AChE- and NGFr-labeling precedes neuronal death of axotomized septal-diagonal band neurons: Reversal by intraventricular NGF infusion. Exp. Neurol. 113:1991;93-108.
7. Fischer W., Bjorklund A., Chen K., Gage F. H. NGF improves spatial memory in aged rodents as a function of age. J. Neurosci. 11:1991;1889-1907.
8. Fischer W., Gage F. H., Björklund A. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1:1989;34-45.
9. Fischer W., Wictorin K., Bjorklund A., Williams L. R., Varon S., Gage F. H. Amelioration of cholinergic neurons atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 329:1987;65-68.
10. Gage F. H., Wolff J. A., Rosenberg M. B., Xu L., Yee J-K., Shults C., Friedmann T. Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience. 23:1987;795-807.
11. Haroutunian V., Kanof P., Davis K. L. Pharmacological alleviation of cholinergic lesion induced memory deficits in rats. Life Sci. 37:1985;945-952.
12. Hedreen J. C., Bacon S. J., Price D. L. A modified histochemical technique to visualise acetylcholinesterase-containing axons. J. Histochem. Cytochem. 33:1984;134-140.
13. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6:1986;2155-2162.
14. Hefti F., Dravid A., Hartikka J. Chronic intraventricular injections of Nerve Growth Factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293:1984;305-311.
15. Kaplitt M. G., During M. J. Transfer and expression of potentially therapeutic genes into mammalian central nervous systemin vivo. Viral Vectors. 1996;Academic Press, New York. p. 193-210.
16. Kaplitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., O'Malley K. L., During M. J. Long term gene expression and phenotypic correction using adeno associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-153.
17. Kawaja M. D., Rosenberg M. B., Yoshida K., Gage F. H. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J. Neurosci. 12:1992;2849-2864.
18. Klein R. L., Muir D. F., King M. A., Peel A. L., Zolotukhin S., Möller J. C., Krüttgen A., Heymach J. V. Jr., Muzyczka N., Meyer E. M. Long-term actions of vector-derived NGF or BDNF on choline acetyltransferase and TRK receptor levels in the adult rat basal forebrain. Neuroscience. 1999.
19. Leff S. E., Spratt S. K., Rendahl K. G., Mandel R. J. In vivo L-dopa production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts requires co-expression of GTP-cyclohydrolase I with tyrosine hydroxylase. Exp. Neurol. 151:1998;249-264.
20. Leff S. E., Spratt S. K., Snyder R. O., Mandel R. J. Restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated virus in an animal model of Parkinson's disease. Neuroscience. 1998.
21. Li J., Samulski R. J., Xiao X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71:1997;5236-5243.
22. Mandel R. J., Clevenger D. G., Nagy D., Jaret T. M., Morten M., Leff S. E. Bioactivity of syngeneic rat fibroblasts genetically modified to express human nerve growth factor as demonstrated by enhanced survival of medial septal cholinergic neurons after fimbria-fornix transection. Exp. Neurol. 135:1995;167.
23. Mandel R. J., Rendahl K. G., Spratt K. S., Snyder R. O., Cohen L. K., Leff S. E. Characterization of intrastriatal recombinant adeno-associated virus mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydroxylase I in a rat model of Parkinson's disease. J. Neurosci. 18:1998;4271-4284.
24. Mandel R. J., Spratt S. K., Snyder R. O., Leff S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14083-14088.
25. Martínez-Serrano A., Björklund A. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc. Natl. Acad. Sci. USA. 95:1998;1858-1863.
26. Martínez-Serrano A., Fischer W., Bjorklund A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron. 15:1995;473-484.
27. Martínez-Serrano A., Fischer W., Söderstrom S., Ebendal T., Bjorklund A. Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain. Proc. Natl. Acad. Sci. USA. 93:1996;6355-6360.
28. Martínez-Serrano A., Hantzopoulos P. A., Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: Neurotrophic effects on cholinergic neurons. Eur. J. Neurosci. 8:1996;727-735.
29. Martínez-Serrano A., Lundberg C., Horellou P., Fischer W., Bentlage C., Campbell K., McKay R. D. G., Mallet J., Bjorklund A. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J. Neurosci. 15:1995;5668-5680.
30. McCown T. J., Xiao X., Li J., Breese G. R., Samulski R. J. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713:1996;99-107.
31. Phelps C. H., Gage F. H., Growdon J. H., Hefti F., Harbaugh R., Johnston M. V., Khachaturian Z. S., Mobley W. C., Price D. L., Raskind M., Simpkins J., Thal L. J., Woodcock J. Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol. Aging. 10:1989;205-207.
32. Rosenberg M. B., Friedmann T., Robertson R. C., Tuszynski M., Wolff J. A., Breakefield X. O., Gage F. H. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science. 242:1988;1575-1578.
33. Snyder R. O., Miao C. H., Patijn G. A., Spratt S. K., Danos O., Gown A. M., Winther B., Meuse L., Cohen L. K., Thompson A. R., Kay M. A. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16:1997;270-276.
34. Tuszynski M. H., Roberts J., Senut M. C., Hsu, Gage F. H. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 3:1996;305-314.
35. Ullrich A., Gray A., Berman C., Dull T. J. Human-nerve growth factor gene sequence highly homologous to that of mouse. Nature. 303:1983;821-825.
36. Venero J. L., Hefti F., Knusel B. Trophic effects of exogenous nerve growth factor on rat striatal cholinergic neurons: Comparison between intraparenchymal and intraventricular administration. Mol. Pharmacol. 49:1996;303-310.
37. Williams L. R. Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male rats. Neurobiol. Aging. 12:1991;39-46.
38. Williams L. R., Varon S., Peterson G. M., Wictorin K., Fischer W., Bjorklund A., Gage F. H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA. 83:1986;9231-9235.
39. Winkler J., Ramirez G. A., Kuhn H. G., Peterson D. A., Day-Lollini P. A., Stewart G. R., Tuszynski M. H., Gage F. H., Thal L. J. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann. Neurol. 41:1997;82-93.